TY  - JOUR
AU  - De Miguel, Rosa
AU  - Delgado Vázquez, Rafael
AU  - Rubio García, Rafael
AU  - Pulido Ortega, Federico
AU  - Arribas, José Ramón
PY  - 2020
DO  - 10.1016/j.ebiom.2020.102779
UR  - https://hdl.handle.net/20.500.14352/105929
T2  - eBioMedicine
AB  - Background: We investigated the efficacy of a switch to dolutegravir plus lamivudine in aviremic individuals without evidence of persistent lamivudine resistance-associated mutations in baseline proviral DNA popula- tion sequencing.Methods:...
LA  - eng
M2  - 1
PB  - Elsevier
KW  - Dolutegravir
KW  - Lamivudine
KW  - Resistance
TI  - Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
TY  - journal article
VL  - 55
ER  -